Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Acorda Therapeutics
>
The Importance of a Long Range Investment Perspective
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 6215720"]Premarket doesn’t mean $&!... here’s an article on reality, which reinforces your vapid posts to rally excitement</p><p>:</p><p>Generally speaking long term investing is the way to go. But unfortunately, some companies simply don't succeed. To wit, the Acorda Therapeutics, Inc. (<a href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-acor/acorda-therapeutics?utm_medium=finance_user&utm_source=apple&utm_campaign=Intro_ticker&blueprint=311229" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-acor/acorda-therapeutics?utm_medium=finance_user&utm_source=apple&utm_campaign=Intro_ticker&blueprint=311229" rel="nofollow">NASDAQ:ACOR</a>) share price managed to fall 66% over five long years. That's an unpleasant experience for long term holders. And some of the more recent buyers are probably worried, too, with the stock falling 44% in the last year. The falls have accelerated recently, with the share price down 17% in the last three months.[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 6215720"]Premarket doesn’t mean $&!... here’s an article on reality, which reinforces your vapid posts to rally excitement : Generally speaking long term investing is the way to go. But unfortunately, some companies simply don't succeed. To wit, the Acorda Therapeutics, Inc. ([URL='https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-acor/acorda-therapeutics?utm_medium=finance_user&utm_source=apple&utm_campaign=Intro_ticker&blueprint=311229']NASDAQ:ACOR[/URL]) share price managed to fall 66% over five long years. That's an unpleasant experience for long term holders. And some of the more recent buyers are probably worried, too, with the stock falling 44% in the last year. The falls have accelerated recently, with the share price down 17% in the last three months.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Acorda Therapeutics
>
The Importance of a Long Range Investment Perspective
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Acorda Therapeutics
>
The Importance of a Long Range Investment Perspective
>